Should Asia lead in waiving drug patent protections?

Question

Accepted Answer

Asia Should Lead in Waiving Drug Patent Protections

Prime Minister Tan Sri Muhyiddin Yassin has advocated for Asia to take the lead in dismantling patent protections for life-saving medicines, enabling the production of more affordable generic versions for critical diseases like Covid-19 and HIV/AIDS. He welcomed the US administration's intention to support a temporary waiver of intellectual property rights for Covid-19 vaccines, calling for a fundamental transformation of the existing pharmaceutical patent system.
Call for Total Transformation of Pharmaceutical Patents

Muhyiddin proposed that innovations such as drugs, vaccines, and medical devices should be removed from individual patent rights and replaced with a system of global property rights. This aligns with Article 25(1) of the Universal Declaration of Human Rights, which he cited as a basis for ensuring health as a global public good. He argued that merely pausing patent enforcement is insufficient and that the entire system requires dismantling.
Shifting Towards Health as a Global Public Good

To effectively combat pandemics, Muhyiddin asserted that Asia must move beyond a purely nationalistic approach to health services. Instead, there should be a strategic investment in health as a collective global asset, similar to how individual nations treat education, security, or environmental protection. This perspective frames health infrastructure as a critical component of the global commons, benefiting all through shared investment and responsibility.
Addressing Vaccine Distribution Disparities

The Prime Minister highlighted significant inequalities in global vaccine distribution, noting that the wealthiest 27 countries possess 35.5% of available vaccines while representing only 10.5% of the world's population. The United States alone accounted for 20% of all vaccine doses administered globally. In contrast, while China and India exported approximately 48% and 34% of their vaccine production respectively, the US and UK exported significantly less, at only 1.1% and 4% of their respective productions.

Reading history

Hide →

This history is cleared when the page is closed.

Should Asia lead in waiving drug patent protections?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends